Sturamustine
Sturamustine, also known as dehydroepiandrosterone 17β-N--N-nitrosourea, is a synthetic androstane steroid and a C17β nitrosourea conjugate of dehydroepiandrosterone which was developed as a cytostatic antineoplastic agent for the treatment of hormone-dependent tumors but was never marketed. It was synthesized in 1982.
